Trials / Completed
CompletedNCT05721612
Titanium Platelet-rich Fibrin in Sinus Floor Elevation Through Flapless Transcrestal Approach
Evaluation of the Use of Titanium Platelet-rich Fibrin in Sinus Floor Elevation Through Flapless Transcrestal Approach ( a Randomized Controlled Clinical Trial)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Hams Hamed Abdelrahman · Academic / Other
- Sex
- All
- Age
- 25 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence flapless transcrestal sinus floor elevation is minimally invasive technique which is used in moderately defected maxilla. Aim of the study: to evaluate both clinical and radiographic outcomes in sinus floor elevation following dental implant placement using flapless transcrestal sinus lift approach with Titanium platelet rich fibrin (TPRF) as a sole sinus graft material compared to Platelet rich fibrin (PRF).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Flapless transcrestal sinus lift approach with TPRF | Including 8 patients who will be treated by flapless transcrestal sinus floor elevation using the TPRF as a sole grafting material. |
| OTHER | Flapless transcrestal sinus lift approach with PRF | Including 8 patients who will be treated by flapless transcrestal sinus floor elevation using the PRF as a sole grafting material. |
Timeline
- Start date
- 2022-03-15
- Primary completion
- 2023-01-30
- Completion
- 2023-02-05
- First posted
- 2023-02-10
- Last updated
- 2023-02-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05721612. Inclusion in this directory is not an endorsement.